Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Ethylnorepinephrine hydrochloride [USP]
RN: 3198-07-0
UNII: X94OZJ468Y
InChIKey: NZDMRJGAFPUTMZ-UHFFFAOYSA-N

Classification Codes

  • Drug / Therapeutic Agent
  • Human Data

Molecular Formula

  • C10-H15-N-O3.Cl-H

Molecular Weight

  • 233.693
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Ethylnorepinephrine hydrochloride [USP]

Synonyms

  • 1-(3,4-Dihydroxyphenyl)-1-hydroxy-2-aminobutane hydrochloride
  • 1-(3,4-Dihydroxyphenyl)-2-amino-1-butanol hydrochloride
  • alpha-(1-Aminopropyl)-3,4-dihydroxybenzyl alcohol hydrochloride
  • alpha-(1-Aminopropyl)protocatechuyl alcohol hydrochloride
  • alpha-Ethylnorepinephrine hydrochloride
  • Bronkephrine
  • Butanefrine hydrochloride
  • Ethyl norepinephrine hydrochloride
  • Ethylnoradrenaline hydrochloride
  • Ethylnorepinephrine HCl
  • Ethylnorepinephrine hydrochloride
  • Ethylnorsuprarenin hydrochloride
  • UNII-X94OZJ468Y

Systematic Names

  • 1,2-Benzenediol, 4-(2-amino-1-hydroxybutyl)-, hydrochloride
  • Benzyl alcohol, alpha-(1-aminopropyl)-3,4-dihydroxy-, hydrochloride

Registry Numbers

CAS Registry Number

  • 3198-07-0

FDA UNII

  • X94OZJ468Y

Other Registry Number

  • 3422-29-5

Related Registry Number

  • 536-24-3 (Parent)

System Generated Number

  • 0003198070

Molecular Formulas

Molecular Formula

  • C10-H15-N-O3.Cl-H

Molecular Formula Fragments

  • C10-H15-N-O3
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

1S/C10H15NO3.ClH/c1-2-7(11)10(14)6-3-4-8(12)9(13)5-6;/h3-5,7,10,12-14H,2,11H2,1H3;1H

InChIKey

NZDMRJGAFPUTMZ-UHFFFAOYSA-N

Smiles

c1(cc(c(O)cc1)O)[C@@H]([C@@H](CC)[NH3+])O.[ClH-]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
human TDLo intramuscular 18ug/kg (0.018mg/kg) CARDIAC: CHANGE IN RATE

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION
Journal of Pharmacology and Experimental Therapeutics. Vol. 81, Pg. 269, 1944.
human TDLo intravenous 9ug/kg (0.009mg/kg) VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

CARDIAC: CHANGE IN RATE

VASCULAR: PULSE PRESSURE INCREASE
Journal of Pharmacology and Experimental Therapeutics. Vol. 81, Pg. 269, 1944.
human TDLo subcutaneous 36ug/kg (0.036mg/kg) VASCULAR: PULSE PRESSURE INCREASE

CARDIAC: CHANGE IN RATE
Journal of Pharmacology and Experimental Therapeutics. Vol. 81, Pg. 269, 1944.
mouse LD50 intravenous 117mg/kg (117mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 81, Pg. 269, 1944.
rat LDLo subcutaneous 160mg/kg (160mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 81, Pg. 269, 1944.